Table 1.
Baseline characteristics | All surviving CKRT patients n = 45 |
Intact survival n = 14 |
Higher FSS at ICU discharge n = 31 |
p-value |
---|---|---|---|---|
Female | 19 (42%) | 6 (32%) | 18 (69%) | 0.954 |
Age, years | 4 (0.8–11) | 4.5 (0.8–12) | 4 (0.8–10) | 0.720 |
Total number of comorbidities | 2 (1, 4) | 2.5 (1, 5) | 2 (1, 4) | 0.412 |
Genetic comorbidity | 7 (16%) | 5 (71%) | 2 (29%) | 0.023` |
Tracheostomy on admission | 1 (2%) | 1 (100%) | 0 | 0.331` |
G-tube dependent on admission | 6 (13%) | 4 (67%) | 2 (33%) | 0.065` |
Baseline FSS | 6 (6, 9) | 8.5 (6, 17) | 6 (6, 6) | 0.007 |
PELOD on ICU admission | 12 (10, 31) | 10.5 (0, 31) | 22 (10, 31) | 0.247 |
Cardiopulmonary Resuscitation | 4 (9%) | 1 (25%) | 3 (75%) | 1.000` |
New seizure | 4 (9%) | 2 (50%) | 2 (50%) | 0.578` |
Mechanical ventilation | 40 (89%) | 12 (30%) | 28 (70%) | 0.639` |
Length of invasive mechanical ventilation, days | 8 (3, 32) | 5 (1, 8) | 11 (5, 34) | 0.056 |
≥ 10 days | 3 (14%) | 19 (86%) | 0.013 | |
Highest OI | 8.5 (3, 19.6) | 5 (2.4, 23.4) | 9.3 (3, 19.6) | 0.515 |
Days on sedation | 8 (2, 25) | 3.5 (1, 8) | 10 (0, 34) | 0.127 |
≥ 9 days | 3 (14%) | 18 (86%) | 0.023 | |
Days on neuromuscular blockade | 1 (0, 5) | 0 (0, 3) | 2 (0, 7) | 0.097 |
≥ 1 day | 5 (19%) | 22 (81%) | 0.025 | |
Days on parenteral nutrition | 8 (0, 17) | 5 (0, 10) | 8 (3, 25) | 0.192 |
Days on CKRT | 9 (3, 18) | 5 (2, 8) | 12 (6, 27) | 0.020 |
Repeat CKRT | 3 (7%) | 0 | 3 (100%) | 0.541` |
PELOD at CKRT start | 31 (12, 32) | 26.5 (10, 40) | 32 (12, 32) | 0.630 |
% fluid overload at CKRT start | 34.5 (11, 70) | 26.5 (2.6, 49) | 42.5 (18, 74) | 0.124 |
Hemodialysis | 26 (58%) | 8 (31%) | 18 (69%) | 0.003 |
CKRT, continuous kidney replacement therapy; FSS, Functional Status Scale; GI, Gastrointestinal; ICU, intensive care unit; OI, oxygenation index; OR, operating room